Steven J. Romano
CIK 1639860 · EVP and Chief R&D Officer · last filed 2026-05-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
24
Lifetime Open-Market Net
$234.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 3 of 3
24 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-05-09 | Keenova Therapeutics plc (MNK) Delisted | Buy (P) | +900 | $50.4K | EDGAR |
| 2016-01-05 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | +4,365 | $0 | EDGAR |
| 2015-12-04 | Keenova Therapeutics plc (MNK) Delisted | Buy (P) | +700 | $50.8K | EDGAR |
| 2015-07-02 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | +3,326 | $0 | EDGAR |
Showing 21–24 of 24
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.